850 ANDRX 675
Pill imprint 850 ANDRX 675 has been identified as Metformin hydrochloride 850 mg.
Metformin is used in the treatment of diabetes, type 2; insulin resistance syndrome; female infertility; polycystic ovary syndrome and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy.
Metformin 850 mg is not subject to the Controlled Substances Act.
See also related documents.
Metformin hydrochloride Images
- Imprint:
-
850
ANDRX 675 - Strength:
- 850 mg
- Color:
- White
- Size:
- 13.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
povidone
hypromellose 2910
polyethylene glycol 400
titanium dioxide
- Drug Class:
- Non-sulfonylureas
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 62037-0675
| NDC Code | Manufacturer / Repackager |
|---|---|
| 55045-2905 | Dispensing Solutions Inc. (repackager) |
| 53002-1422 | Pharmedix (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Metformin Hydrochloride resources
- Metformin
- Metformin (Wolters Kluwer)
- Metformin Extended-Release Tablets (Wolters Kluwer)
- Metformin Solution (Wolters Kluwer)
- metformin (Cerner Multum)
- metformin (Micromedex) - Includes Dosage Information
- Metformin Hydrochloride (AHFS DI)
- Metformin (FDA)
- Metformin Extended Release (FDA)
- Metformin Hydrochloride (Wolters Kluwer)
Search Again
